Basit öğe kaydını göster

dc.contributor.authorBasaran, Seher
dc.contributor.authorUyguner, Zehra Oya
dc.contributor.authorGulec, Cagri
dc.contributor.authorSayin, Gozde Yesil
dc.contributor.authorKayserili, Hulya
dc.contributor.authorTurgut, Gozde Tutku
dc.contributor.authorAltunoglu, Umut
dc.contributor.authorSivrikoz, Tugba Sarac
dc.contributor.authorToksoy, Guven
dc.contributor.authorKalayci, Tugba
dc.contributor.authorAvci, Sahin
dc.contributor.authorKaraman, Birsen
dc.date.accessioned2022-02-18T09:28:52Z
dc.date.available2022-02-18T09:28:52Z
dc.identifier.citationTurgut G. T. , Altunoglu U., Sivrikoz T. S. , Toksoy G., Kalayci T., Avci S., Karaman B., Gulec C., Basaran S., Sayin G. Y. , et al., "Functional loss of ubiquitin-specific protease 14 may lead to a novel distal arthrogryposis phenotype", CLINICAL GENETICS, 2022
dc.identifier.issn0009-9163
dc.identifier.othervv_1032021
dc.identifier.otherav_407fedc5-d4d4-4ff9-bf76-fcc32e6bc2b7
dc.identifier.urihttp://hdl.handle.net/20.500.12627/177317
dc.identifier.urihttps://doi.org/10.1111/cge.14117
dc.description.abstractMultiple congenital contractures (MCC) comprise a number of rare, non-progressive conditions displaying marked phenotypic and etiologic heterogeneity. A genetic cause can be established in approximately half of the affected individuals, attributed to genetic defects in the formation and functioning of the central and peripheral nervous system, neuromuscular junctions, skeletal muscles, and connective tissue. Ubiquitin-specific protease 14 (USP14) encodes a major proteasome-associated deubiquitinating enzyme with an established dual role as an inhibitor and an activator of proteolysis, maintaining protein homeostasis. Usp14-deficient mice show a phenotype similar to lethal human MCC phenotypes, with callosal anomalies, muscle wasting, and early lethality, attributed to neuromuscular junction defects due to decreased monomeric ubiquitin pool. We describe a new, autosomal recessive MCC phenotype in three fetuses from two different branches of a consanguineous family, presenting with distal arthrogryposis, underdevelopment of the corpus callosum, and dysmorphic facial features. Exome sequencing identified a biallelic 4-bp deletion (c.233_236delTTCC; p.Leu78Glnfs*11, SCV002028347) in USP14, and sequencing of family members showed segregation with the phenotype. RT-qPCR experiment in an unaffected heterozygote revealed that mutant USP14 was expressed, indicating that abnormal transcript escapes nonsense-mediated mRNA decay. We propose that herein described fetuses represent the first human phenotype of USP14 loss, with callosal anomalies and/or cortical malformations, multiple contractures, and recognizable dysmorphic facial features.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectGenetics
dc.subjectMolecular Biology
dc.subjectGenetics (clinical)
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectGENETİK VE HAYAT
dc.subjectTıbbi Genetik
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.titleFunctional loss of ubiquitin-specific protease 14 may lead to a novel distal arthrogryposis phenotype
dc.typeMakale
dc.relation.journalCLINICAL GENETICS
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.contributor.firstauthorID3388797


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster